Tumor-associated dendritic cells (TADCs) secreted CXCL1, which in turn increased the expression of the CSC markers CD44 and CD133 on the SW620 CRC cell line and promoted their stemness (Fig. 6C). This evidence concerns the gene CD44 and neoplasm.